Drugs / Omega-3 Long Chain Fatty Acid
last change Jun 2016 re-read 3 minutes ago

Omega-3 Long Chain Fatty Acid

Developed for
psychotic disorder
Investigated by
National Institute of Mental Health (NIMH) · University of California, San Diego

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01429454 Aug 2011 → Jun 2016 psychotic disorder University of California, San Diego Completed Missed primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Omega-3 Long Chain Fatty Acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT01429454 ↗
Route Oral “administered as oral capsules” NCT01429454 ↗